179 related articles for article (PubMed ID: 11336643)
1. Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages.
Atemezem A; Mbemba E; Vassy R; Slimani H; Saffar L; Gattegno L
Biochem J; 2001 May; 356(Pt 1):121-8. PubMed ID: 11336643
[TBL] [Abstract][Full Text] [Related]
2. Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages.
Rabehi L; Seddiki N; Benjouad A; Gluckman JC; Gattegno L
AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1605-15. PubMed ID: 9870313
[TBL] [Abstract][Full Text] [Related]
3. Human alpha-fetoprotein binds to primary macrophages.
Atemezem A; Mbemba E; Marfaing R; Vaysse J; Pontet M; Saffar L; Charnaux N; Gattegno L
Biochem Biophys Res Commun; 2002 Aug; 296(3):507-14. PubMed ID: 12176010
[TBL] [Abstract][Full Text] [Related]
4. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
[TBL] [Abstract][Full Text] [Related]
5. Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.
Maeda K; Yoshimura K; Shibayama S; Habashita H; Tada H; Sagawa K; Miyakawa T; Aoki M; Fukushima D; Mitsuya H
J Biol Chem; 2001 Sep; 276(37):35194-200. PubMed ID: 11454872
[TBL] [Abstract][Full Text] [Related]
6. Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope.
Staudinger R; Wang X; Bandrés JC
Biochem Biophys Res Commun; 2001 Aug; 286(1):41-7. PubMed ID: 11485305
[TBL] [Abstract][Full Text] [Related]
7. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1alpha-binding activity.
Meta A; Torigoe N; Ito Y; Arakaki R; Nakashima H; Sugimura K
Mol Immunol; 1999 Dec; 36(18):1249-54. PubMed ID: 10684964
[TBL] [Abstract][Full Text] [Related]
9. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
[TBL] [Abstract][Full Text] [Related]
10. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.
Rabehi L; Ferriere F; Saffar L; Gattegno L
Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416
[TBL] [Abstract][Full Text] [Related]
11. The Src kinase Lyn is required for CCR5 signaling in response to MIP-1beta and R5 HIV-1 gp120 in human macrophages.
Tomkowicz B; Lee C; Ravyn V; Cheung R; Ptasznik A; Collman RG
Blood; 2006 Aug; 108(4):1145-50. PubMed ID: 16621960
[TBL] [Abstract][Full Text] [Related]
12. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
13. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.
Laurence JS; Blanpain C; De Leener A; Parmentier M; LiWang PJ
Biochemistry; 2001 Apr; 40(16):4990-9. PubMed ID: 11305915
[TBL] [Abstract][Full Text] [Related]
14. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
[TBL] [Abstract][Full Text] [Related]
15. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
[TBL] [Abstract][Full Text] [Related]
16. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Baba M; Takashima K; Miyake H; Kanzaki N; Teshima K; Wang X; Shiraishi M; Iizawa Y
Antimicrob Agents Chemother; 2005 Nov; 49(11):4584-91. PubMed ID: 16251299
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
Bondue A; Jao SC; Blanpain C; Parmentier M; LiWang PJ
Biochemistry; 2002 Nov; 41(46):13548-55. PubMed ID: 12427015
[TBL] [Abstract][Full Text] [Related]
18. Interaction of soluble CD4 with the chemokine receptor CCR5.
Wang X; Staudinger R
Biochem Biophys Res Commun; 2003 Aug; 307(4):1066-9. PubMed ID: 12878220
[TBL] [Abstract][Full Text] [Related]
19. Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage.
Borrajo A; Ranazzi A; Pollicita M; Bellocchi MC; Salpini R; Mauro MV; Ceccherini-Silberstein F; Perno CF; Svicher V; Aquaro S
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31234437
[No Abstract] [Full Text] [Related]
20. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
